Studies say GSK bird flu vaccine able to kill multiple strains

03/5/2007 | Forbes · Wall Street Journal, The

A pair of studies show GlaxoSmithKline's prepandemic flu vaccine appears to work against multiple strains of the H5N1 bird flu virus. Although the vaccine was based on just one strain, the studies said the drug provides cross-immunity by recognizing and killing a different strain.

View Full Article in:

Forbes · Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC